Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth
Related Experiment Video
Updated: Mar 16, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Marco Gerling1, Nikè V J A Büller2, Leonard M Kirn1,3
1Center for Innovative Medicine, Department of Biosciences and Nutrition, Karolinska Institutet, NOVUM, Hälsovägen 7, 14183 Huddinge, Sweden.
Abstract:
A role for Hedgehog (Hh) signalling in the development of colorectal cancer (CRC) has been proposed. In CRC and other solid tumours, Hh ligands are upregulated; however, a specific Hh antagonist provided no benefit in a clinical trial. Here we use Hh reporter mice to show that downstream Hh activity is unexpectedly diminished in a mouse model of colitis-associated colon cancer, and that downstream Hh signalling is restricted to the stroma. Functionally, stroma-specific Hh activation in mice markedly reduces the tumour load and blocks progression of advanced neoplasms, partly via the modulation of BMP signalling and restriction of the colonic stem cell signature. By contrast, attenuated Hh signalling accelerates colonic tumourigenesis. In human CRC, downstream Hh activity is similarly reduced and canonical Hh signalling remains predominantly paracrine. Our results suggest that diminished downstream Hh signalling enhances CRC development, and that stromal Hh activation can act as a colonic tumour suppressor.
Insights
Diminished Hedgehog (Hh) signalling promotes colorectal cancer (CRC) development. Activating stromal Hh signalling unexpectedly suppresses colon tumors, suggesting a novel therapeutic strategy for CRC.
Area of Science:
- Oncology
- Developmental Biology
- Cancer Signalling
Background:
- Hedgehog (Hh) signalling is implicated in colorectal cancer (CRC) development, with upregulated Hh ligands observed in many solid tumors.
- However, clinical trials using Hh antagonists have yielded no benefit, suggesting a complex role for Hh in CRC.
Purpose of the Study:
- To investigate the role of downstream Hh signalling activity in a mouse model of colitis-associated colon cancer.
- To determine the therapeutic potential of modulating Hh signaling in colorectal cancer.
Main Methods:
- Utilized Hh reporter mice to assess downstream Hh activity in a colitis-associated colon cancer model.
- Investigated the effects of stroma-specific Hh activation and attenuated Hh signalling on tumor progression.
- Analyzed downstream Hh activity in human CRC samples.
Main Results:
- Downstream Hh activity was unexpectedly diminished and restricted to the stroma in a mouse model of colon cancer.
- Stroma-specific Hh activation significantly reduced tumor load and blocked advanced neoplasm progression in mice.
- Attenuated Hh signalling accelerated colonic tumorigenesis, while human CRC showed similarly reduced downstream Hh activity.
Conclusions:
- Diminished downstream Hh signalling enhances colorectal cancer development.
- Stromal Hh activation acts as a colon tumor suppressor, potentially through modulation of BMP signalling and colonic stem cell signatures.
- Targeting stromal Hh signalling represents a potential therapeutic strategy for colorectal cancer.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

